Working… Menu

A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. (MEDIOLA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02734004
Recruitment Status : Active, not recruiting
First Posted : April 12, 2016
Last Update Posted : September 29, 2020
Iqvia Pty Ltd
Information provided by (Responsible Party):